United States Will Provide COVID-19 Vaccines Internationally

In a move to continue widespread vaccination, the Biden Administration is planning to share the US supply and expected production of its AstraZeneca COVID-19 vaccines to other countries. This could mean up to 60 million doses of the vaccine being sent internationally in the coming months.

This news comes from a report by the Associated Press.

“Given the strong portfolio of vaccines that the US already has and that have been authorized by the FDA, and given that the AstraZeneca vaccine is not authorized for use in the U.S., we do not need to use the AstraZeneca vaccine here during the next several months,” White House COVID-19 coordinator Jeff Zients said. “Therefore the US is looking at options to share the AstraZeneca doses with other countries as they become available.”

The vaccine will need to be reviewed by the Food and Drug Administration (FDA) before distribution. While there is no definite timetable for (FDA) review, there are currently 10 million doses of the AstraZeneca vaccine and approximately another 50 million in various stage of production.

The doses will be donated by the US government and no final determination has been made on which countries will receive the vaccines.